Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
abiraterone decanoate (Astellas Pharma)
- Development stage
- Unknown
- Lead developer
- Astellas Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Intramuscular
01
Overview
Abiraterone decanoate is a long-acting prodrug of abiraterone, designed for intramuscular (IM) depot administration. It provides controlled release of abiraterone, a potent inhibitor of steroid 17-alpha-hydroxylase (CYP17), which is essential for androgen biosynthesis. By inhibiting CYP17, it suppresses the production of testosterone and other androgens that can drive the growth of prostate cancer cells. Abiraterone decanoate is being developed primarily for advanced or metastatic prostate cancer as an alternative to daily oral abiraterone acetate, aiming to improve pharmacokinetics and patient compliance by reducing dosing frequency and potentially minimizing peak-related toxicities. The drug is under investigation in clinical trials for advanced prostate cancer[2][3][4][5][6].
- Other names
- abiraterone decanoate
02
Targets
CYP17A1 (Steroid 17-alpha-hydroxylase/C17,20 lyase)
Beyond the preview
Go deeper on abiraterone decanoate (Astellas Pharma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on abiraterone decanoate (Astellas Pharma).